Asthma Control and Asthma Medication Use among Swedish Elite Endurance Athletes

Table 5

Use of asthma medication by Swedish elite endurance athletes and a reference group of patients with current asthma and a statistical comparison between the two groups.

	Athletes	References	value
SABA/LABA
Never	32 (30)	40 (17)
Sometimes	30 (28)	101 (42)
Less than 2 months	0 (0)	12 (5)
More than 2 months	4 (4)	16 (7)
Daily	42 (39)	73 (30)	0.101
ICS
Never	56 (52)	135 (56)
Sometimes	14 (13)	34 (14)
Less than 2 months	1 (1)	8 (3)
More than 2 months	3 (3)	9 (4)
Daily	34 (31)	56 (23)	0.099
ICS + LABA
Never	64 (59)	126 (52)
Sometimes	5 (5)	17 (7)
Less than 2 months	3 (3)	5 (2)
More than 2 months	3 (3)	7 (3)
Daily	33 (31)	87 (36)	0.326

To compare the two groups with regard to use of asthma medication, the subjects were dichotomized into those who did and did not use SABA/LABA, ICS, or ICS + LABA daily; comparison of proportions of daily users of SABA/LABA, ICS, and ICS + LABA between the study groups; ICS, inhaled corticosteroids; SABA/LABA, short-acting β2-agonists/long-acting β2-agonists.